Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2026
Pharma
Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears
With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.
Angus Liu
Jan 15, 2026 10:42am
JPM26: Jazz inks $200M priority review voucher sale
Jan 14, 2026 3:55pm
JPM26, Day 3: AbbVie, AZ, Novo execs share visions for ’26
Jan 14, 2026 2:29pm
Fierce Biotech
JPM26: Sanofi looks ahead to lingering US policy hurdles
Jan 14, 2026 2:28pm
JPM26: Novo CEO outlines R&D, marketing tactics for 2026
Jan 14, 2026 10:05am
AZ's $80B revenue target 'very much within reach,' CFO says
Jan 14, 2026 10:00am
